Restrictions on Grant. Except as otherwise specifically permitted in this Agreement, you may not: (a) modify or create any derivative works of any Software or documentation, including translation or localization; (code written to published APIs (application programming interfaces) for the Software shall not be deemed derivative works); (b) copy the Software except as provided in this Agreement or elsewhere by Telmar; (c) separate Software, which is licensed as a single product, into its component parts.
Restrictions on Grant. The license granted pursuant to Article 2 is subject to the following restrictions:
(a) SNAPSHOT shall not copy, adapt, modify, recast, translate, shorten, expand, reverse engineer, decompile or disassemble the Product.
(b) SNAPSHOT must not alter, or assert rights, title or interest in, the Trademarks of Synercard.
(c) SNAPSHOT shall distribute the Software only in the form provided by Synercard.
(d) SNAPSHOT shall not sell or use for production Product purchased for Promotional Use.
(e) To the best of their ability SNAPSHOT must ensure that End Users register their purchase of the Software;
(1) SNAPSHOT must not make or give any representations or warranties on ~ behalf of Synercard as to the quality, merchantability, fitness for a particular use or purpose, or any other features of the Product, except as set out in this Agreement.
(g) SNAPSHOT shall reference the Product and Synercard on its website.
(h) SNAPSHOT shall comply with all laws, rules, regulations and industry standards existing with respect to the Product and the performance by SNAPSHOT of its obligations under this Agreement. SNAPSHOT shall not export the Products directly or indirectly outside of the Territory.
Restrictions on Grant. Except as otherwise specifically permitted in this Agreement, You may not: (a) modify or create any derivative works of the Software, including translation or localization (code written to published APIs (application programming interfaces) for the Software shall not be deemed derivative works); (b) copy the Software, except as provided in this Agreement or elsewhere by TeamSolutions; (c) separate the Software, which is licensed as a single product, into its component parts; (d) reverse engineer, decompile, or disassemble or otherwise attempt to derive the source code for the Software (except to the extent applicable laws specifically prohibit such restriction); (e) remove or alter any trademark, logo, copyright, or other proprietary notices, legends, symbols, or labels in the Software; (f) publish any results of benchmark tests run on the Software to a third party without TeamSolutions’ prior written consent; or (g) redistribute, encumber, sell, rent, lease, sublicense, or use the Software or otherwise transfer rights to the Software.
Restrictions on Grant. The sublicense grant set forth in this Agreement is subject to the following conditions and restrictions, in addition to the other terms of this Agreement:
(a) The sublicense granted hereunder shall not be construed to confer any rights upon Pharmasset by implication, estoppel, or otherwise as to any other technology of WU or of Apath, except as expressly set forth in this Agreement;
(b) As between Pharmasset and Apath, title to Intellectual Property and Tangible Property shall remain in WU and/or Apath, and no rights are to be transferred to Pharmasset hereunder other than as specifically set forth herein; additionally, the transfer of Tangible Property to Pharmasset by Apath is not to be considered a conditional or unconditional sale of goods; provided, however, that Pharmasset will own all rights, including all intellectual property rights, inventions, ideas, know-how, trade secrets, discoveries and other subject matter Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets and asterisks [***], have been separately filed with the Commission. conceived and reduced to practice solely by Pharmasset’s employees, by third parties retained by Pharmasset or by such Pharmasset employees and third parties working together;
(c) Pharmasset shall not distribute Intellectual Property and/or Tangible Property and Tangible Property Improvements (as defined in Section 5 below) to any third party (including any Affiliate) without obtaining the prior written consent of Apath. Once the consent of Apath is granted (which consent shall not be unreasonably withheld or delayed), Pharmasset shall be entitled to distribute the Intellectual Property and/or Tangible Property and Tangible Property Improvements to its Affiliates, who shall be bound by the terms of this Agreement by accepting such Intellectual Property and/or Tangible Property or Tangible Property Improvements. Prior to providing the Tangible Property or Tangible Property Improvement to any Affiliate, Pharmasset shall notify Apath of the identity of such Affiliate, and Pharmasset shall provide such Affiliate with the terms and conditions of this Agreement and take reasonable measures to ensure that the terms are understood by such Affiliate. Pharmasset shall guarantee the full and complete performance of all duties and obligations hereunder by any such Affiliate.
(d) If through the course of research within the Field of Use ...
Restrictions on Grant. Nothing contained in this Agreement shall be construed as granting Sperry any right or license to manufacture or otherwise produce, cause to be manufactured or otherwise produced, or to sell or knowingly cause to be sold, any of the other products currently produced or owned by eVS. 5 6 ARTICLE 5 DISCLOSURE OF TECHNOLOGY BY eVS
Restrictions on Grant. 6.1 Except as otherwise specifically permitted in this Agreement, you may not: (a) modify or create any derivative works of any Software or documentation, including translation or localization; (code written to published APIs (application programming interfaces) for the Software shall not be deemed derivative works); (b) copy the Software except as provided in this Agreement or elsewhere by BitDefender; (c) separate Software, which is licensed as a single product, into its component parts; (d) sublicense or permit simultaneous use of the Software by more than one user;
(e) reverse engineer, decompile, or disassemble or otherwise attempt to derive the source code for any Product the Software (except to the extent applicable laws specifically prohibit such restriction); (f) redistribute, encumber, sell, rent, lease, sublicense, use the Software in a timesharing or service bureau arrangement, or otherwise transfer rights to any Software. You may NOT transfer the Software under any circumstances; (g) remove or alter any trademark, logo, copyright or other proprietary notices, legends, symbols or labels in the Product(s); (h) publish any results of benchmark tests run on any Software to a third party without BitDefender prior written consent; or (i) use any Software on a system with more CPUs than the number licensed, by more users than have been licensed, on more computers or computing devices than the number licensed, or by more developers than the number licensed, as applicable.
Restrictions on Grant. 4.1. Except as otherwise specifically permitted in this Agreement, Licensee may not:
Restrictions on Grant. Except as otherwise specifically permitted in this Agreement:-
a) You shall not use the Software for the provision of any service for the benefit of third parties;
b) You shall not modify or create any derivative works of any Software or Documentation, including translation or localisation (code written to published Application Programming Interfaces (APIs) for the Software shall not be deemed derivative works);
c) You shall not copy the Software except as provided in this Agreement or elsewhere by Netduma;
d) You shall not separate the Software, which is licensed as a single product, into its component parts;
e) You shall not sub-license or permit simultaneous use of the Software by more than one Unit;
f) You shall not reverse engineer or otherwise reduce to human readable form, decompile, or disassemble or otherwise attempt to derive or determine the source code or the logic therein for the Software (except to the extent applicable laws specifically prohibit such restriction);
g) You shall not redistribute, encumber, rent, lease, sublicense, use the Software in a timesharing or service bureau arrangement, or otherwise transfer rights to any Software;
h) You shall not remove or alter any trademark, logo, copyright or other proprietary notices, legends, symbols or labels in the Product;
i) YOU SHALL NOT USE THE SOFTWARE FOR COMMERCIAL USES.
j) You shall not tamper with, disassemble, misuse, neglect or damage the Product.
Restrictions on Grant. 7.1 No grant of Award Shares shall be made to any Selected Participant under the Scheme where any Director and/or such Selected Participant is in possession of unpublished inside information in relation to the Company or any of its subsidiaries or where dealings in Shares have been suspended or dealings in Shares by any Director are prohibited under any code or requirement of the Listing Rules or any applicable legal or regulatory requirement from time to time or where such grant of the Award Shares would result in a breach of the Scheme Limit (as defined below).
7.2 In respect of the administration of the Scheme, the Company shall comply with all applicable disclosure regulations including those imposed by the Listing Rules.
Restrictions on Grant. Except as otherwise specifically permitted in this Agreement, Licensee may not: (a) modify or create any derivative works of any Software or documentation, including translation or localization; (code written to published APIs (application programming interfaces) for the Software shall not be deemed derivative works); (b) copy the Software except as provided in this Agreement or elsewhere by KSTI; (c) separate Software, which is licensed as a single product, into its component parts(d) reverse engineer, decompile, or disassemble or otherwise attempt to derive the source code for any Product the Software (except to the extent applicable laws specifically prohibit such restriction); (e) redistribute, encumber, sell, rent, lease, sublicense, use the Software in a timesharing or service bureau arrangement, or otherwise transfer rights to any Software. Licensee may NOT transfer the Software under any circumstances; (f) remove or alter any trademark, logo, copyright or other proprietary notices, legends, symbols or labels in the Product(s); (g) publish any results of benchmark tests run on any Software to a third party without KSTI prior written consent. With advance notification to the user, KSTI reserves the right to change any usernames assigned by users, at the sole discretion of KSTI. At its sole discretion, KSTI reserves the right to set usage limitations on specific users. Licensees requests for product support can be made via email to xxxxxxx@xxxxxxxxxxxxx.xxx. Support requests are prioritized depending upon their severity and KSTI will endeavor to respond to support requests within a 48-hour period. KSTI makes no guarantees about the availability of the Software and service. KSTI will endeavor to ensure continuous availability, although from time-to-time, availability may be limited due to updates to the Software, or to other factors beyond the control of KSTI.
